Skip to main content
. Author manuscript; available in PMC: 2011 Mar 16.
Published in final edited form as: Am Heart J. 2008 Dec 16;157(3):402–411. doi: 10.1016/j.ahj.2008.10.016

Table II.

Comparison for impedance measurement techniques for cardiac applications

Device Advantages Limitations Assumptions
Band electrode method Noninvasive, low-cost, simple to use, continuous time-dependent monitoring
Can give assessment of relative cardiac output changes in response to therapy
Some questionable accuracy and consistency of cardiac output measurements for late-stage, chronic heart failure, and patients in unstable conditions
Unresolved discrepancies in measurement (pulmonary edema, body size, irregular blood flow, blood volume)
No valve defects
No respiratory diseases
No renal failure, no implanted pacing device
Implanted device-based method Noninvasive (external), early detection of symptoms before hospitalization
Continuous monitoring
Sensitive to fluid accumulation, localized to thorax
Invasive (implant), some unresolved impedance sources (blood volume, lung resistivity)
No cardiac output, SVR, or filling pressure monitor
No detection of peripheral edema or hypertension
No valve defects
No acute pulmonary processes (eg, pneumonia)